Header cover image

Investing Ideas
/
Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Results

11

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

11 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	GMAB Genmab	DKK 1,450.00	-8.9%	-34.6%	DKK 92.1b	DKK 2,396.59	PE19.6x	E23.7%	n/a
	GUBRA Gubra	DKK 610.00	28.7%	413.5%	DKK 9.9b	n/a	PS44.4x	n/a	0%
	ALK B ALK-Abelló	DKK 158.00	-5.4%	67.2%	DKK 34.9b	DKK 181.20	PE44.5x	E21.5%	0%
	BAVA Bavarian Nordic	DKK 169.10	-18.9%	10.6%	DKK 13.3b	DKK 317.00	PE11.9x	E-0.06%	n/a
	STRAP Strategic Partners	DKK 940.00	-0.01%	23.7%	DKK 39.2m	n/a	PB2.4x	n/a	n/a
	BIOPOR BioPorto	DKK 1.70	-3.0%	-30.6%	DKK 730.4m	DKK 3.00	PS21.6x	E-35.0%	n/a
	CHEMM ChemoMetec	DKK 447.80	-10.6%	22.3%	DKK 7.8b	DKK 545.00	PE57.2x	E17.2%	0.9%
	HLUN B H. Lundbeck	DKK 44.72	2.3%	33.9%	DKK 42.7b	DKK 50.14	PE16.5x	E8.6%	1.6%
	STENO Stenocare	DKK 1.39	12.1%	-56.6%	DKK 27.8m	n/a	PS12.4x	n/a	n/a
	ZEAL Zealand Pharma	DKK 720.50	-17.9%	129.3%	DKK 50.9b	DKK 1,018.50	PS662.2x	E65.8%	n/a
	NOVO B Novo Nordisk	DKK 711.00	-8.1%	1.1%	DKK 3.2t	DKK 938.04	PE33.3x	E14.4%	1.4%

Page 1 of 1